Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06063317
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2023-09-14
Brief Title:
A Study of OnCARlytics CF33-CD19 in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors OASIS
Sponsor:
Imugene Limited
Organization:
Imugene Limited
Organization Data
Organization:
Imugene Limited
Class:
INDUSTRY
Study ID:
CF33-CD19-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Imugene Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None